Empowered Funds
TRDA icon

Empowered Funds’s Entrada Therapeutics TRDA Stock Holding History

Empowered Funds’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$283K Buy
+44,513
New +$309K ﹤0.01% 2068

Other funds holding TRDA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Merck & Co
Merck & Co Rahway, New Jersey $820M AUM 395.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Empowered Funds's TRDA Position: Q3 2026 in Review

Empowered Funds opened a new position in Entrada Therapeutics (TRDA) in Q3 2026: 44,513 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #2068 among its holdings.

84 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.

  • Empowered Funds held 44,513 shares of Entrada Therapeutics worth $283K as of Q3 2026.
  • Entrada Therapeutics was a new Empowered Funds position in Q3 2026.
  • Entrada Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2068 holding.
  • 84 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.